home / stock / atrc / atrc news


ATRC News and Press, AtriCure Inc. From 04/27/21

Stock Information

Company Name: AtriCure Inc.
Stock Symbol: ATRC
Market: NASDAQ
Website: atricure.com

Menu

ATRC ATRC Quote ATRC Short ATRC News ATRC Articles ATRC Message Board
Get ATRC Alerts

News, Short Squeeze, Breakout and More Instantly...

ATRC - AtriCure EPS beats by $0.04, beats on revenue

AtriCure (ATRC): Q1 Non-GAAP EPS of -$0.32 beats by $0.04; GAAP EPS of -$0.38 beats by $0.01.Revenue of $59.28M (+11.4% Y/Y) beats by $3.22M.Press Release For further details see: AtriCure EPS beats by $0.04, beats on revenue

ATRC - AtriCure Reports First Quarter 2021 Financial Results

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced first quarter 2021 financial results. “Our growth in the first quarter is a testament of our team’s strong execut...

ATRC - AtriCure nominates former Medtronic executive as new Board Chair

AtriCure (ATRC) has named B. Kristine (Kris) Johnson as its new Board Chair. The current chair Scott Drake and another director Mark Lanning are not standing for reelection at the end of their terms in May 2021, the company said.A Board member at the company since 2017, Ms. Johnson sits ...

ATRC - AtriCure Names B. Kristine Johnson Board Chair

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that B. Kristine (Kris) Johnson has been named Board Chair. In addition, the Company announced that Scott Drake and Mark Lanning wi...

ATRC - AtriCure to Announce First Quarter 2021 Financial Results

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will release its first quarter 2021 financial results on Tuesday, April 27, 2021. AtriCure will host a confer...

ATRC - AtriCure (ATRC)Presents At Oppenheimer 31st Annual Healthcare Conference - Slideshow

The following slide deck was published by AtriCure, Inc. in conjunction with this event. For further details see: AtriCure (ATRC)Presents At Oppenheimer 31st Annual Healthcare Conference - Slideshow

ATRC - AtriCure to Participate at the Oppenheimer 31st Annual Healthcare Conference

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that the company will be participating in the upcoming Oppenheimer 31 st Annual Healthcare Conference. A...

ATRC - AtriCure Inc (ATRC) Q4 2020 Earnings Call Transcript

Image source: The Motley Fool. AtriCure Inc (NASDAQ: ATRC) Q4 2020 Earnings Call Feb 23, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: AtriCure Inc (ATRC) Q4 2020 Earnings Call Transcript

ATRC - AtriCure, Inc. (ATRC) CEO Mike Carrel on Q4 2020 Results - Earnings Call Transcript

AtriCure, Inc. (ATRC) Q4 2020 Earnings Conference Call February 23, 2021 16:30 ET Company Participants Lynn Lewis - Gilmartin Group Mike Carrel - President & Chief Executive Officer Angie Wirick - Chief Financial Officer Conference Call Participants Mike Matson - Needham & Company Mat...

ATRC - AtriCure EPS beats by $0.07, misses on revenue

AtriCure (ATRC): Q4 Non-GAAP EPS of -$0.18 beats by $0.07; GAAP EPS of -$0.42 misses by $0.13.Revenue of $57.73M (-5.9% Y/Y) misses by $0.23M.Shares -5.03%.Press Release For further details see: AtriCure EPS beats by $0.07, misses on revenue

Previous 10 Next 10